biospecimen_aliquot__bcr_aliquot_barcode	tcga-e9-a1r0-01a-22d-a16d-09
biospecimen_aliquot__bcr_aliquot_uuid	c09eaa03-c14c-4a96-a505-4d999e45270e
biospecimen_aliquot__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_aliquot__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113421788
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-06-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a16d
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	2.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e9-a1r0-01a-22d
biospecimen_analyte__bcr_analyte_uuid	eaa1602e-0880-4216-a417-5857ce43bc75
biospecimen_analyte__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_analyte__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e9-a1r0
biospecimen_diagnostic_slides__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	187c58ea-132e-4b3c-bad0-7f59101d5c4d
biospecimen_normal_control__bcr_patient_barcode	tcga-e9-a1r0
biospecimen_normal_control__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_portion__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_portion__bcr_portion_barcode	tcga-e9-a1r0-01a-22
biospecimen_portion__bcr_portion_uuid	3454730f-7e0a-4774-a817-9a04a03d9be7
biospecimen_portion__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_portion__date_of_creation	2011-04-01
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	22
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	10.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e9-a1r0-01a-22d
biospecimen_protocol__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_protocol__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_sample__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_sample__bcr_sample_uuid	e61781e7-6c4e-4a6f-8f8d-22896b1243ca
biospecimen_sample__days_to_collection	44
biospecimen_sample__initial_weight	400
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e9-a1r0.dd0adc20-2059-435e-9eb4-351c87d7cbeb.pdf
biospecimen_sample__pathology_report_uuid	dd0adc20-2059-435e-9eb4-351c87d7cbeb
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	79bdc020-426c-41df-8b45-be0425815405
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e9-a1r0-01a-11-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
biospecimen_slide__bcr_sample_barcode	tcga-e9-a1r0-01a
biospecimen_slide__bcr_slide_barcode	tcga-e9-a1r0-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	76d55fb8-5518-496c-9a80-de81a3073232
biospecimen_slide__image_file_name	tcga-e9-a1r0-01a-02-tsb.76d55fb8-5518-496c-9a80-de81a3073232.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	5
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	65
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e9-a1r0
biospecimen_tumor_sample__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
clinical_drug__bcr_drug_barcode	tcga-e9-a1r0-d29805
clinical_drug__bcr_drug_uuid	b560f532-8633-49e9-a9c7-ae671251f874
clinical_drug__bcr_patient_barcode	tcga-e9-a1r0
clinical_drug__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
clinical_drug__form_completion_date	2012-3-29
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	doxorubicin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ended_days_to	103
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	36
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	80
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	320
clinical_follow_up__bcr_followup_barcode	tcga-e9-a1r0-f29795
clinical_follow_up__bcr_followup_uuid	6dd81350-f039-458b-a58d-50192ee6c328
clinical_follow_up__bcr_patient_barcode	tcga-e9-a1r0
clinical_follow_up__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-29
clinical_follow_up__last_contact_days_to	435
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	58
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e9-a1r0
clinical_patient__bcr_patient_uuid	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d
clinical_patient__birth_days_to	-21394
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-7-28
clinical_patient__gender	female
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	0
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	12
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__patient_id	a1r0
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__tissue_source_site	e9
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A1R0-01A-22D-A16D-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A1R0-01A-22D-A16D-09.bed.meta
manually_curated__id	tcga-e9-a1r0-01a-22d-a16d-09
manually_curated__md5sum	89296d5461179444facf764567023bd7
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	c09eaa03-c14c-4a96-a505-4d999e45270e
manually_curated__tumor_tag	brca
